June 8, 2026
BILLERICA, Mass. - Bruker Corporation announced the commissioning of a novel BioSpec™ 18 Tesla preclinical MRI, the world’s highest-field horizontal-bore MRI system, at the Champalimaud Foundation in Lisbon, Portugal. The BioSpec 18T system provides increased spatial resolution and sensitivity, enabling advanced magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) methods for cancer and [...]
June 4, 2026
Melbourne, Australia – Legion BioSolutions Limited and OnQ Software Pty Ltd are pleased to announce that they have signed a dealer agreement appointing Legion BioSolutions as the regional partner for QLIMS, OnQ Software’s flagship laboratory information management system, across the genomics sector in the United Arab Emirates, Saudi Arabia, Bahrain, Kuwait, Oman, Qatar, and Jordan. Under [...]
SOPHiA GENETICS Signs Strategic Collaboration MOU with Leading Global Cancer Center
June 4, 2026
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two [...]
Bruker Showcases Expanding Microbiology & Infection Diagnostics Portfolio at ASM Microbe 2026
June 4, 2026
WASHINGTON, D.C. - At ASM Microbe 2026, Bruker Corporation’s (Nasdaq: BRKR) Microbiology & Infection Diagnostics (BMID) division is demonstrating its expanding portfolio and innovations across microbial identification, sepsis diagnostics, molecular testing, and NGS workflows, advancing clinical research, and faster, actionable infectious disease diagnostics. During the ASM 2026 meeting, Bruker showcases the expanded clinical capabilities of [...]
Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization
June 4, 2026
New integrated workflow combines icIEF fractionation and mass photometry Enables direct characterization of aggregation and size within icIEF-resolved charge variants Four-hour workflow reduces development risk and accelerates biosimilar manufacturing MINNEAPOLIS and OXFORD, England -- Bio‑Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, [...]
June 4, 2026
Strategic partnership integrates Pluristyx's clinical-grade iPSC platform into Made Scientific's CDMO services, giving developers a single-source path from cell line to commercial supply. PRINCETON, N.J. and SEATTLE -- Made Scientific, Inc., a leading U.S.-based clinical- and commercial-stage cell therapy contract development and manufacturing organization (CDMO), and Pluristyx, a leading provider of RUO and GMP induced [...]
Scispot Raises $8M Series A to Help Life Sciences Labs Move Faster
June 4, 2026
Already used by 100+ labs, the Kitchener-Waterloo company helps life sciences teams automate digital lab work, manage millions of samples, and keep lab operations traceable. KITCHENER-WATERLOO, ON - Scispot, the Canadian company behind the AI-native operating layer for modern labs, today announced an $8 million USD Series A led by Avenue Growth Partners, a Washington, [...]
Distek Launches BIOne Core Software for Streamlined Bioprocess Data Management
June 3, 2026
North Brunswick, NJ – Distek, Inc., a leading manufacturer of bioprocessing equipment, announces the release of their BIOne Core Software, an advanced, cloud-based historian software platform designed exclusively for BIOne Bioprocess Controllers. Delivered as a Software-as-a-Service (SaaS) solution, BIOne Core enables users to easily visualize, monitor, and manage critical bioprocess data while minimizing on-premise IT infrastructure. Designed [...]
Fujifilm Announces Leadership Changes to Enhance Life Sciences Capabilities
June 3, 2026
VALHALLA, N.Y. -- FUJIFILM Holdings America Corporation today announces additional leadership responsibilities for three key leaders in its Life Sciences Group companies. Tomoyuki Hasegawa will now serve as CEO of FUJIFILM Biotechnologies California, a global CDMO for biologics and advanced therapies. He will also continue to serve as General Manager of Fujifilm Life Sciences Strategic [...]
STARLIMS Appoints Max Schultz as Chief Executive Officer
June 3, 2026
Veteran software executive to lead STARLIMS through its next phase of growth HOLLYWOOD, Fla. -- STARLIMS, a global leader in enterprise laboratory informatics software, today announced the appointment of Max Schultz as Chief Executive Officer. This leadership transition comes at a time of growth for STARLIMS, with the company accelerating product innovation, expanding its portfolio [...]

